Bruker Daltonics

Increased demand has led to an overwhelming volume of LC-MS/MS data and a requirement for analytical software that can simplify its interpretation. This poster highlights a new, comprehensive software solution capable of eliminating the otherwise overwhelming efforts of manual data interpretation.

Bruker Corporation today announced that is has closed the acquisition of ZONTAL Inc., an innovative platform provider for the digital transformation of the analytical laboratory, and for integrated biopharma technical data solutions.

At the 71st Annual Society for Mass Spectrometry (ASMS) meeting, Technology Networks had the pleasure of speaking with Rohan Thakur, president of Life Sciences Mass Spectrometry at Bruker Daltonics. We discussed the new product launches from Bruker and focused specifically on the applications of the company’s newest mass spectrometer, the timsTOF Ultra, for immunopeptidomics.

Need a routine analytical technique that can provide protein expression profiling and targeted drug imaging? MALDI Imaging is used to determine the spatial distribution of molecules in a tissue section, for more complete multiomic information.

Introducing midia-PASEF®, a groundbreaking DIA scan mode utilizing overlapping quadrupole windows for comprehensive ion analysis.

Lipid nanoparticles (LNPs) have emerged as effective delivery vehicles for mRNA vaccines and nucleic acid-based drugs. Hence, the analysis of their composition, stability, and biological interactions is essential in drug development and delivery.

PreOmics GmbH announces the launch of its new ENRICHiST™ kits, which enable biologically unbiased enrichment of lower abundant plasma and serum proteins onto non-functionalized paramagnetic particles.

Bruker Corporation highlights its commitment to develop novel technology and improved mass spec workflows for the applied markets requirements of robustness, ease-of-use, and highest confidence in food/beverage, forensic/toxicology, industrial and environmental analysis.

timsTOF Ultra Further Advances Quantitative Spatial and Single-cell 4D-Proteomics and 4D-Lipidomics™, Immunopeptidomics, PTM and Protein-Protein Interactions Analysis - with Speed and Robustness.

While depleting abundant proteins can facilitate the detection of low-concentration biomarkers, such methods can be labor-intensive, costly and can result in sample loss. Discover how parallel accumulation, serial elution and fragmentation (PASEF) can support researchers to achieve accurate large-scale plasma proteomics.